Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international […]
BIG Summit themes: Resilient investment, MFN threat, patients in the center Read More »
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are
BIG Summit panel breaks down risks and opportunities coming out of DC Read More »
We could be in for another big year of biotech M&A. A busy 2025, in both licensing and M&A in biopharma, saw over 4,000
BIG Summit: Experts see signs of M&A momentum in 2026 Read More »
China is becoming an increasingly influential player in the global biotech market. More than a third of U.S. licensing deals this year have involved
BIG Summit: Seeking opportunities while navigating risks of global trade Read More »
The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off on March 2, 2025, and will convene industry leaders in sunny
Meet us in Miami for the BIO Investment and Growth Summit Read More »
Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies venture capital principles to achieve philanthropic goals—can provide vital funding sources
The BIG Summit meets at the intersection of patient advocacy and venture investment Read More »
We sometimes imagine the inventor of a patent as a lone vanguard leading the charge toward innovation, but in the era of team research
Who invented what? BIO IP panel tackles joint inventorship Read More »
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees
BIO 2025 IP Conference: Challenging times for the laws that drive innovation Read More »
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11
BIO on the American Road: Indiana, a production powerhouse, is still expanding Read More »
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship
Ahead of BIO IP Conference, research highlights why biotech needs strong patents Read More »
